Business Context and Reporting Period
This Form 6-K filing by Ambev S.A. reports on transactions with securities and derivatives conducted in January 2025, as required by Article 11 of CVM Instruction #358/2002. The report details the company's repurchase of its own common shares (treasury stock) executed through Santander Corretora. The filing was signed on February 10, 2024, though the transaction data pertains to January 2025.
Key Financial Metrics
The filing focuses exclusively on share repurchase activity and does not provide operational financial metrics such as revenue, profit, cash flow, margins, or debt levels.
- Initial Treasury Balance: 29,807,211 Common Shares
- Total Shares Purchased: 39,090,000 Common Shares
- Final Treasury Balance: 68,897,211 Common Shares
- Transaction Volume: The filing lists numerous individual transactions with a total volume in Brazilian Reais (R$) exceeding R$ 400 million based on the sum of listed transaction values.
- Price Range: Shares were purchased at prices ranging approximately from R$ 10.79 to R$ 11.53.
Material Changes
The primary material change reported is a significant increase in the company's treasury stock position. The number of outstanding shares held in treasury increased by approximately 131% during the reporting month, rising from roughly 29.8 million to 68.9 million shares. This represents a substantial reduction in the company's float.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, forward-looking guidance, outlook statements, or specific risk factors. It is a statutory disclosure of share transactions only. No unusual items or contingencies are described in the provided text.
Investor Verification Checklist
- Verify the total cash outflow for the repurchase program by summing the "Volume (R$)" column in the full transaction schedule.
- Confirm the impact of the 39.09 million share repurchase on the company's total outstanding share count and earnings per share (EPS).
- Review the company's latest 20-F or 40-F filing to understand the remaining authorization for share buybacks and the company's liquidity position post-repurchase.
- Check the date discrepancy: The filing is signed in February 2024 but reports transactions for January 2025; verify if this is a clerical error in the signature date or a specific reporting lag.